The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

BACKGROUND: Valproate is widely accepted as a drug of first choice for patients with generalised onset seizures, and its broad spectrum of efficacy means it is recommended for patients with seizures that are difficult to classify. Lamotrigine and topiramate are also thought to possess broad spectrum...

Full description

Saved in:
Bibliographic Details
Main Authors: Marson, Anthony G, Al-Kharusi, Asya M, Alwaidh, Muna, Appleton, Richard, Baker, Gus A, Chadwick, David W, Cramp, Celia, Cockerell, Oliver C, Cooper, Paul N, Doughty, Julie, Eaton, Barbara, Gamble, Carrol, Goulding, Peter J, Howell, Stephen J L, Hughes, Adrian, Jackson, Margaret, Jacoby, Ann, Kellett, Mark, Lawson, Geoffrey R, Leach, John Paul, Nicolaides, Paola, Roberts, Richard, Shackley, Phil, Shen, Jing, Smith, David F, Smith, Philip E M, Smith, Catrin Tudur, Vanoli, Alessandr a, Williamson, Paula R
Format: Artigo
Language:Inglês
Published: 2007
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2039891/
https://ncbi.nlm.nih.gov/pubmed/17382828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(07)60461-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items